Enanta Pharmaceuticals (ENTA) Current Deferred Tax Assets (2014 - 2016)

Enanta Pharmaceuticals' (ENTA) quarterly Current Deferred Tax Assets came in at $1.1 million in Q2 2016, down 34.72% YoY from $1.8 million in Q3 2015, and down 27.45% on a QoQ basis from $1.6 million in Q1 2016.

Enanta Pharmaceuticals (ENTA) Current Deferred Tax Assets (2014 - 2016) Analysis & Trends

Enanta Pharmaceuticals (ENTA) has 3 years of Current Deferred Tax Assets data on file, last reported at $1.1 million in Q2 2016.

  • Quarterly Current Deferred Tax Assets fell 34.72% year-over-year to $1.1 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $1.1 million (down 34.72% YoY) and the FY2015 annual result came in at $1.4 million, down 86.99% from the prior year.
  • Current Deferred Tax Assets slipped to $1.1 million in Q2 2016, from $1.6 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $11.2 million in Q2 2014 to a low of $1.1 million in Q2 2016.
  • A 3-year average of $3.6 million and a median of $1.6 million in 2015 frame the typical range for Current Deferred Tax Assets.
  • The widest YoY moves for Current Deferred Tax Assets: up 17.28% in 2015, down 86.99% in 2015.
  • Tracing ENTA's Current Deferred Tax Assets over 3 years: stood at $1.3 million in 2014, then gained by 17.28% to $1.6 million in 2015, then dropped by 27.45% to $1.1 million in 2016.
  • The last three Current Deferred Tax Assets figures came in at $1.1 million (Q2 2016), $1.6 million (Q1 2016), and $1.6 million (Q4 2015), per Business Quant data.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Enanta Pharmaceuticals 383.29 Mn 193.78 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2016 1.15 Mn
Jun 30, 2016 1.15 Mn
Mar 31, 2016 1.58 Mn
Mar 31, 2016 1.58 Mn
Dec 31, 2015 1.58 Mn
Dec 31, 2015 1.58 Mn
Sep 30, 2015 1.45 Mn
Sep 30, 2015 1.45 Mn
Jun 30, 2015 1.76 Mn
Jun 30, 2015 1.76 Mn
Mar 31, 2015 1.45 Mn
Mar 31, 2015 1.45 Mn
Dec 31, 2014 1.35 Mn
Dec 31, 2014 1.35 Mn
Sep 30, 2014 11.12 Mn
Sep 30, 2014 11.12 Mn
Jun 30, 2014 11.18 Mn
Jun 30, 2014 11.18 Mn